Eva L. Feldman MD, PhD, Russell N. DeJong Professor of Neurology at Michigan Medicine is a renowned neurologist and neuroscientist who has devoted her career towards understanding the etiology of neurological disorders and developing new treatments. With over 30 years of continuous funding from the National Institutes of Health (NIH), her reputation is internationally recognized and she directs a research program of 25 scientists at Michigan Medicine. Her pioneering studies on neurological disorders with an emphasis on amyotrophic lateral sclerosis (ALS) have influenced clinical practice. She currently leads 3 multi-institutional NIH grants aimed at understanding the pathophysiology of ALS. She is Principal Investigator or Co-Investigator on an additional 5 NIH grants supporting her work on the neurological complications of metabolic diseases. She served as the Principal Investigator on the first two FDA-approved clinical trials of stem cell transplantation in amyotrophic lateral sclerosis (ALS) and is funded by the NIH to move this therapy forward for Alzheimer’s disease, and by the Center for Disease Control for her pioneering work on identifying environmental pollutants as an underlying contributing cause of ALS. With an H index of 105, her findings are published in over 460 manuscripts, 70 book chapters, and 4 books and she has trained over 100 basic science and clinical fellows.
Dr. Feldman was the inaugural Director of the A. Alfred Taubman Medical Research Institute from 2007-2017. She served as President of the American Neurological Association from 2011-2013, the third woman to hold this position in 130 years. Dr. Feldman is a fellow of the American Association for the Advancement of Science and a member of the Johns Hopkins Society of Scholars, the Association of University Professors and the National Academy of Medicine, where she chairs the Neurology and Psychiatry section. She is the only faculty member from the University of Michigan Medical Center to receive both the Early Career and the Advanced Career Distinguished Achievement Awards. She has received numerous other awards, including lifetime achievement awards from the American Diabetes Association, the Juvenile Diabetes Research Foundation, the Endocrine Society and the Society for Neuroscience. In 2016, Professor Feldman received the National Physician of the Year for Clinical Excellence in New York City and has been elected by her peers as one of the Best Doctors in America for 18 consecutive years.